China OKs its first mRNA vaccine, from drugmaker CSPC

China Clears First Homegrown mRNA Covid Vaccine

China Clears First Homegrown mRNA Covid Vaccine - CSPC Pharmaceutical reports winning approval from National Medical Products Administration for shot targeting omicron variant

China approves its first mRNA COVID-19 vaccine

CSPC Pharmaceutical Group says Chinese authorities have approved its domestically developed mRNA vaccine against COVID-19.

China OKs Its First mRNA Vaccine From Drugmaker CSPC

China has approved its first domestically developed mRNA vaccine against COVID-19, CSPC Pharmaceutical Group Ltd 1093.HK said on Wednesday, a major achievement in a country that has declined to use Western COVID shots to support domestic research.  China, whose home-grown vaccines are seen as less effective than the Moderna and Pfizer-BioNTech mRNA shots, has been racing to develop vaccines using messenger RNA (mRNA) technology since early 2020.…

China approves first homegrown mRNA COVID-19 vaccine for emergency use

China's drugmaker, CSPC Pharmaceutical Group Limited, announced its messenger RNA (mRNA) COVID-19 vaccine has been approved for emergency use by the National Medical Products Administration, making it the country's first domestically developed mRNA shot.

China OKs its first mRNA vaccine from drugmaker CSPC

Long-awaited approval comes as infections have fallen sharply across China

China approves first domestic mRNA COVID-19 vaccine

In a study of 4,000 participants, the vaccine showed efficacy of 85.3 percent 14 to 28 days after a booster vaccination.